Design, synthesis, molecular modeling, and biological evaluations of novel chalcone based 4-Nitroacetophenone derivatives as potent anticancer agents targeting EGFR-TKD

References

• Ahmad, S. M., Meher, R. K., Baitharu, I., & Nayak, B. (2022). Molecular dynamic simulation, free binding energy calculation of thiazolo-[2,3-b]quinazolinone derivatives against EGFR-TKD and their anticancer activity. Results in Chemistry, 4, 100418. https://doi.org/10.1016/j.rechem.2022.100418
   Google Scholar
• Ahmad, S. M., Meher, R. K., & Nayak, B. (2023). Molecular modeling and simulations of some antiviral drugs, benzylisoquinoline alkaloid, and coumarin molecules to investigate the effects on Mpro main viral protease inhibition. Biochemistry and Biophysics Reports, 34, 101459. https://doi.org/10.1016/j.bbrep.2023.101459
   PubMedGoogle Scholar
• Behera, S., Monalisa, K., Meher, R. K., Mohapatra, S., Madkami, S. K., Das, P. K., Naik, P. K., & Naik, S. K. (2022). Phytochemical fidelity and therapeutic activity of micropropagated Curcuma amada Roxb.: A valuable medicinal herb. Industrial Crops and Products, 176, 114401. https://doi.org/10.1016/j.indcrop.2021.114401
   Web of Science ®Google Scholar
• Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/10.1063/1.448118
   Web of Science ®Google Scholar
• Bharti, R., Dey, G., Ojha, P. K., Rajput, S., Jaganathan, S. K., Sen, R., & Mandal, M. (2016). Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer. Oncogene, 35(30), 3965–3975. https://doi.org/10.1038/onc.2015.466
   PubMed Web of Science ®Google Scholar
• Brooks, B. R., Brooks, C. L., Mackerell, A. D., Nilsson, L., Petrella, R. J., Roux, B., Won, Y., Archontis, G., Bartels, C., Boresch, S., Caflisch, A., Caves, L., Cui, Q., Dinner, A. R., Feig, M., Fischer, S., Gao, J., Hodoscek, M., Im, W., … Karplus, M. (2009). CHARMM: The biomolecular simulation program. Journal of Computational Chemistry, 30(10), 1545–1614. https://doi.org/10.1002/jcc.21287
   PubMed Web of Science ®Google Scholar
• Carter, C. A., Kelly, R. J., & Giaccone, G. (2009). Small-molecule inhibitors of the human epidermal receptor family. Expert Opinion on Investigational Drugs, 18(12), 1829–1842. https://doi.org/10.1517/13543780903373343
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅ log (N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/10.1063/1.464397
   Web of Science ®Google Scholar
• Dixon, R. A., & Ferreira, D. (2002). Genistein. Phytochemistry, 60(3), 205–211. https://doi.org/10.1016/s0031-9422(02)00116-4
   PubMed Web of Science ®Google Scholar
• El-Azab, A. S., Abdel-Aziz, A. A. M., Ghabbour, H. A., & Al-Gendy, M. A. (2017). Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4 (3H)-quinazolinone analogues. Journal of Enzyme Inhibition and Medicinal Chemistry, 32(1), 1229–1239. https://doi.org/10.1080/14756366.2017.1368504
   PubMed Web of Science ®Google Scholar
• El-Azab, A. S., Al-Omar, M. A., Abdel-Aziz, A. A.-M., Abdel-Aziz, N. I., el-Sayed, M. A.-A., Aleisa, A. M., Sayed-Ahmed, M. M., & Abdel-Hamide, S. G. (2010). Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: Molecular docking study. European Journal of Medicinal Chemistry, 45(9), 4188–4198. https://doi.org/10.1016/j.ejmech.2010.06.013
   PubMed Web of Science ®Google Scholar
• El-Deeb, I. M., Bayoumi, S. M., El-Sherbeny, M. A., & Alaa, A. M. (2010). Synthesis and antitumor evaluation of novel cyclic arylsulfonylureas: ADME-T and pharmacophore prediction. European Journal of Medicinal Chemistry, 45(6), 2516–2530. https://doi.org/10.1016/j.ejmech.2010.02.038
   PubMed Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J., & Fraaije, J. G. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L
   Web of Science ®Google Scholar
• Huether, A., Höpfner, M., Sutter, A. P., Schuppan, D., & Scherübl, H. (2005). Erlotinib induces cell cycle arrest and apoptosis in hepatocellular cancer cells and enhances chemosensitivity towards cytostatics. Journal of Hepatology, 43(4), 661–669. https://doi.org/10.1016/j.jhep.2005.02.040
   PubMed Web of Science ®Google Scholar
• Karthikeyan, C., Sh Narayana Moorthy, N., Ramasamy, S., Vanam, U., Manivannan, E., Karunagaran, D., & Trivedi, P. (2015). Advances in chalcones with anticancer activities. Recent Patents on anti-Cancer Drug Discovery, 10(1), 97–115. https://doi.org/10.2174/1574892809666140819153902
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & Lynn, A. (2014). g_mmpbsa: A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Kumar, A., Sarker, M. N., & Sunanda, P. (2019). The theoretical investigation of HOMO, LUMO, thermophysical properties and QSAR study of some aromatic carboxylic acids using HyperChem programming. International Journal of Chemistry and Technology, 3(1), 26–37. https://doi.org/10.32571/ijct.478179
   Google Scholar
• Latek, D. (2019). Modeling of membrane proteins. In A. Liwo (Ed.), Computational methods to study the structure and dynamics of biomolecules and biomolecular processes. Springer series on bio- and neurosystems (Vol. 8). Cham: Springer. https://doi.org/10.1007/978-3-319-95843-9_12
   Google Scholar
• Laurella, L. C., Mirakian, N. T., Garcia, M. N., Grasso, D. H., Sülsen, V. P., & Papademetrio, D. L. (2022). Sesquiterpene lactones as promising candidates for cancer therapy: Focus on pancreatic cancer. Molecules, 27(11), 3492. https://doi.org/10.3390/molecules27113492
   PubMed Web of Science ®Google Scholar
• Lemmon, M. A., & Schlessinger, J. (2010). Cell signaling by receptor tyrosine kinases. Cell, 141(7), 1117–1134. https://doi.org/10.1016/j.cell.2010.06.011
   PubMed Web of Science ®Google Scholar
• Li, Z. (2017). Structure-based discovery of novel EGFR tyrosine kinase inhibitor [Doctoral dissertation]. State University of New York at Buffalo.
   Google Scholar
• Lindorff-Larsen, K., Piana, S., Palmo, K., Maragakis, P., Klepeis, J. L., Dror, R. O., & Shaw, D. E. (2010). Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins, 78(8), 1950–1958. https://doi.org/10.1002/prot.22711
   PubMed Web of Science ®Google Scholar
• Lobanov, M., Yu, N. S., Bogatyreva., & O. V., Galzitskaya. (2008). Radius of gyration as an indicator of protein structure compactness. Molecular Biology, 42(4), 623–628. https://doi.org/10.1134/S0026893308040195
   Web of Science ®Google Scholar
• Mark, P., & Nilsson, L. (2001). Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. The Journal of Physical Chemistry A, 105(43), 9954–9960. https://doi.org/10.1021/jp003020w
   Web of Science ®Google Scholar
• Masson, K., & Rönnstrand, L. (2009). Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3. Cellular Signalling, 21(12), 1717–1726. https://doi.org/10.1016/j.cellsig.2009.06.002
   PubMed Web of Science ®Google Scholar
• McKillop, D., Partridge, E. A., Kemp, J. V., Spence, M. P., Kendrew, J., Barnett, S., Wood, P. G., Giles, P. B., Patterson, A. B., Bichat, F., Guilbaud, N., & Stephens, T. C. (2005). Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor. Molecular Cancer Therapeutics, 4(4), 641–649. https://doi.org/10.1158/1535-7163.MCT-04-0329
   PubMed Web of Science ®Google Scholar
• Meher, R. K., Mir, S. A., & Anisetti, S. S. (2023). In silico and in vitro investigation of dual targeting Prima-1MET as precision therapeutic against lungs cancer. Journal of Biomolecular Structure & Dynamics, 1–16. https://doi.org/10.1080/07391102.2023.2219323
   Google Scholar
• Meher, R. K., Naik, M. R., Bastia, B., & Naik, P. K. (2018). Comparative evaluation of anti-angiogenic effects of noscapine derivatives. Bioinformation, 14(5), 236–240. https://doi.org/10.6026/97320630014236
   PubMed Web of Science ®Google Scholar
• Meng, X. Y., Zhang, H. X., Mezei, M., & Cui, M. (2011). Molecular docking: A powerful approach for structure-based drug discovery. Current Computer-Aided Drug Design, 7(2), 146–157. https://doi.org/10.2174/157340911795677602
   PubMed Web of Science ®Google Scholar
• Mir, S. A., & Nayak, B. (2022). In silico analysis of binding stability of quercetin with CmpA and in vitro growth inhibition study of cyanobacterial species using Azadirachta indica extracts. Chemistry Africa, 5(3), 691–701. https://doi.org/10.1007/s42250-022-00335-2
   Google Scholar
• Mir, S. A., Dash, G. C., Meher, R. K., Mohanta, P. P., Chopdar, K. S., Mohapatra, P. K., Baitharu, I., Behera, A. K., Raval, M. K., & Nayak, B. (2022). In silico and in vitro evaluations of fluorophoric thiazolo-[2,3-b] quinazolinones as anti-cancer agents targeting EGFR-TKD. Applied Biochemistry and Biotechnology, 194(10), 4292–4318. https://doi.org/10.1007/s12010-022-03893-w
   PubMed Web of Science ®Google Scholar
• Mir, S. A., Muhammad, A., Padhiary, A., Ekka, N. J., Baitharu, I., Naik, P. K., & Nayak, B. (2023). Identification of potent EGFR-TKD inhibitors from NPACT database through combined computational approaches. Journal of Biomolecular Structure & Dynamics, 41(21), 12063–12076. https://doi.org/10.1080/07391102.2023.2171133
   PubMedGoogle Scholar
• Mphahlele, M. J., Maluleka, M. M., Parbhoo, N., & Malindisa, S. T. (2018). Synthesis, evaluation for cytotoxicity and molecular docking studies of benzo [c] furan-chalcones for potential to inhibit tubulin polymerization and/or EGFR-tyrosine kinase phosphorylation. International Journal of Molecular Sciences, 19(9), 2552. https://doi.org/10.3390/ijms19092552
   PubMed Web of Science ®Google Scholar
• Nelson, M. H., & Dolder, C. R. (2006). Lapatinib: A novel dual tyrosine kinase inhibitor with activity in solid tumors. The Annals of Pharmacotherapy, 40(2), 261–269. https://doi.org/10.1345/aph.1G387
   PubMed Web of Science ®Google Scholar
• Nelson, V., Ziehr, J., Agulnik, M., & Johnson, M. (2013). Afatinib: Emerging next-generation tyrosine kinase inhibitor for NSCLC. Oncotargets and Therapy, 6, 135–143. https://doi.org/10.2147/OTT.S23165
   PubMed Web of Science ®Google Scholar
• Özdemir, A., Ciftci, H., Sever, B., Tateishi, H., Otsuka, M., Fujita, M., & Altıntop, M. D. (2022). A new series of indeno [1,2-c] pyrazoles as EGFR TK inhibitors for NSCLC therapy. Molecules, 27(2), 485. https://doi.org/10.3390/molecules27020485
   PubMed Web of Science ®Google Scholar
• Parr, R. G., Szentpály, L. V., & Liu, S. (1999). Electrophilicity index. Journal of the American Chemical Society, 121(9), 1922–1924. https://doi.org/10.1021/ja983494x
   Web of Science ®Google Scholar
• Rahman, M. A. (2011). Chalcone: A valuable insight into the recent advances and potential pharmacological activities, Chemical Sciences Journal, CSJ-29, 1–16.
   Google Scholar
• Ramos, K. S., & Weber, T. J. (2010). Introduction and overview of alterations in cell signaling. In Comprehensive toxicology: Second edition (pp. 447–471). Elsevier.
   Google Scholar
• Saluja, T. S., Kumar, V., Agrawal, M., Tripathi, A., Meher, R. K., Srivastava, K., Gupta, A., Singh, A., Chaturvedi, A., & Singh, S. K. (2020). Mitochondrial stress-mediated targeting of quiescent cancer stem cells in oral squamous cell carcinoma. Cancer Management and Research, 12, 4519–4530. https://doi.org/10.2147/CMAR.S252292
   PubMed Web of Science ®Google Scholar
• Schettino, C., Bareschino, M. A., Ricci, V., & Ciardiello, F. (2008). Erlotinib: An EGF receptor tyrosine kinase inhibitor in non-small-cell lung cancer treatment. Expert Review of Respiratory Medicine, 2(2), 167–178. https://doi.org/10.1586/17476348.2.2.167
   PubMedGoogle Scholar
• Sousa da Silva, A. W., & Vranken, W. F. (2012). ACPYPE-Antechamber python parser interface. BMC Research Notes, 5, 367. https://doi.org/10.1186/1756-0500-5-367
   PubMedGoogle Scholar
• Stamos, J., Sliwkowski, M. X., & Eigenbrot, C. (2002). Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. The Journal of Biological Chemistry, 277(48), 46265–46272. https://doi.org/10.1074/jbc.M207135200
   PubMed Web of Science ®Google Scholar
• Stanley, A., Ashrafi, G. H., Seddon, A. M., & Modjtahedi, H. (2017). Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines. Scientific Reports, 7(1), 3964. https://doi.org/10.1038/s41598-017-04301-8
   PubMedGoogle Scholar
• Subramanian, J., Katta, A., Masood, A., Vudem, D. R., & Kancha, R. K. (2019). Emergence of ERBB2 mutation as a biomarker and an actionable target in solid cancers. The Oncologist, 24(12), e1303–e1314. https://doi.org/10.1634/theoncologist.2018-0845
   PubMed Web of Science ®Google Scholar
• Venkatesan, P., & Sumathi, S. (2010). Piperidine mediated synthesis of n‐heterocyclic chalcones and their antibacterial activity. Journal of Heterocyclic Chemistry, 47(1), 81–84. https://doi.org/10.1002/jhet.268
   Web of Science ®Google Scholar
• WHO (2018). Retrieved from https://www. who. int/health- topics/cancer# tab=tab_1
   Google Scholar
• Zandi, R., Larsen, A. B., Andersen, P., Stockhausen, M. T., & Poulsen, H. S. (2007). Mechanisms for oncogenic activation of the epidermal growth factor receptor. Cellular Signalling, 19(10), 2013–2023. https://doi.org/10.1016/j.cellsig.2007.06.023
   PubMed Web of Science ®Google Scholar
• Zhao, J., Guerrero, A., Kelnar, K., Peltier, H. J., & Bader, A. G. (2017). Synergy between next generation EGFR tyrosine kinase inhibitors and miR-34a in the inhibition of non-small cell lung cancer. Lung Cancer, 108, 96–102. https://doi.org/10.1016/j.lungcan.2017.02.020
   PubMed Web of Science ®Google Scholar